Shopping Cart 0
Cart Subtotal
USD 0

Quanterix Corp (QTRX) - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Quanterix Corp (Quanterix) is a medical equipment provider that offers proteins measurement solutions. The company's products include biomarker detection system, assay kits, single molecule detector and analyzers. It provides clinical sample and outsourced testing, custom assay development, assay feasibility testing and prototype development, assay optimization and assay validation through its innovative accelerator lab. Quanterix's technologies are used in life sciences research, oncology, neurology, inflammatory disease and infectious disease areas. The company offers certificates for analysis that are conducted using its products. It partners with sports and healthcare sectors to detect symptoms and signs of injuries. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Quanterix Corp

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Quanterix Corp Company Overview 5

Quanterix Corp Company Snapshot 5

Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview 5

Quanterix Corp - Pipeline Analysis Overview 8

Quanterix Corp - Key Facts 8

Quanterix Corp - Major Products and Services 9

Quanterix Corp Pipeline Products by Development Stage 10

Quanterix Corp Pipeline Products Overview 12

AccuPSA Test 12

AccuPSA Test Product Overview 12

Antigen Detection Assay - Tuberculosis 13

Antigen Detection Assay - Tuberculosis Product Overview 13

Blood Test - Concussions/TBI 14

Blood Test - Concussions/TBI Product Overview 14

Diagnostic Blood Test - Huntington's Disease 15

Diagnostic Blood Test - Huntington's Disease Product Overview 15

Digital ELISA - Crohn's Disease 16

Digital ELISA - Crohn's Disease Product Overview 16

Digital ELISA Assay - C. Difficile 17

Digital ELISA Assay - C. Difficile Product Overview 17

NeuroFilament Light Assay - Alzheimer's Disease 18

NeuroFilament Light Assay - Alzheimer's Disease Product Overview 18

POC Device - Neurological Injuries 19

POC Device - Neurological Injuries Product Overview 19

Simoa 3.0 20

Simoa 3.0 Product Overview 20

Simoa 4.0 21

Simoa 4.0 Product Overview 21

Simoa 5.0 22

Simoa 5.0 Product Overview 22

SiMoA HD-1 Analyzer - Botulinum Toxin Assay 23

SiMoA HD-1 Analyzer - Botulinum Toxin Assay Product Overview 23

Simoa HD-1 Analyzer - Lung Cancer 24

Simoa HD-1 Analyzer - Lung Cancer Product Overview 24

Simoa HD-1 Analyzer - Pancreatic Cancer 25

Simoa HD-1 Analyzer - Pancreatic Cancer Product Overview 25

SiMoA HD-1 Analyzer - Prostate Cancer Assay 26

SiMoA HD-1 Analyzer - Prostate Cancer Assay Product Overview 26

Quanterix Corp - Key Competitors 27

Quanterix Corp - Key Employees 28

Quanterix Corp - Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Quanterix Corp, Recent Developments 30

May 09, 2018: Quanterix Releases Operating Results for First Quarter 2018 30

Apr 27, 2018: Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone 30

Mar 14, 2018: Quanterix Releases Operating Results for Fourth Quarter and Fiscal Year 2017 31

Mar 08, 2018: New Research Demonstrates Enhanced Sensitivity for Acute HIV Detection Using Quanterix' Simoa Technology 32

Jan 15, 2018: Quanterix Developing Biomarkers for Concussions 33

Jan 10, 2018: Quanterix: Results of Operations and Financial Condition 34

Nov 10, 2017: Quanterix to Showcase New SR-X Ultra-Sensitive Biomarker Detection System at Neuroscience 2017 34

Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017 35

Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 36

Sep 07, 2017: Quanterix To Host Webinar On Predicting The Progression Of Neurodegeneration With A Blood Test 36

Appendix 37

Methodology 37

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Quanterix Corp Pipeline Products by Equipment Type 6

Quanterix Corp Pipeline Products by Development Stage 10


List Of Table

List of Tables

Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview 5

Quanterix Corp Pipeline Products by Equipment Type 6

Quanterix Corp Pipeline Products by Indication 7

Quanterix Corp, Key Facts 8

Quanterix Corp, Major Products and Services 9

Quanterix Corp Number of Pipeline Products by Development Stage 10

Quanterix Corp Pipeline Products Summary by Development Stage 11

AccuPSA Test - Product Status 12

AccuPSA Test - Product Description 12

Antigen Detection Assay - Tuberculosis - Product Status 13

Antigen Detection Assay - Tuberculosis - Product Description 13

Blood Test - Concussions/TBI - Product Status 14

Blood Test - Concussions/TBI - Product Description 14

Diagnostic Blood Test - Huntington's Disease - Product Status 15

Diagnostic Blood Test - Huntington's Disease - Product Description 15

Digital ELISA - Crohn's Disease - Product Status 16

Digital ELISA - Crohn's Disease - Product Description 16

Digital ELISA Assay - C. Difficile - Product Status 17

Digital ELISA Assay - C. Difficile - Product Description 17

NeuroFilament Light Assay - Alzheimer's Disease - Product Status 18

NeuroFilament Light Assay - Alzheimer's Disease - Product Description 18

POC Device - Neurological Injuries - Product Status 19

POC Device - Neurological Injuries - Product Description 19

Simoa 3.0 - Product Status 20

Simoa 3.0 - Product Description 20

Simoa 4.0 - Product Status 21

Simoa 4.0 - Product Description 21

Simoa 5.0 - Product Status 22

Simoa 5.0 - Product Description 22

SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Status 23

SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Description 23

Simoa HD-1 Analyzer - Lung Cancer - Product Status 24

Simoa HD-1 Analyzer - Lung Cancer - Product Description 24

Simoa HD-1 Analyzer - Pancreatic Cancer - Product Status 25

Simoa HD-1 Analyzer - Pancreatic Cancer - Product Description 25

SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status 26

SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description 26

Quanterix Corp, Key Employees 28

Quanterix Corp, Subsidiaries 29

Glossary 39

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Quanterix Corp, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

InBios International Inc

Epic Sciences Inc

Tosoh Bioscience Inc

Qualigen Inc

Promega Corp